Filtered By:
Infectious Disease: Coronavirus
Vaccination: Cancer Vaccines
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 719 results found since Jan 2013.
City of Houston Gets First Doses of Moderna COVID-19 Vaccine
Dylan McGuinness
Houston Chronicle
(MCT)
Dec. 28—A shipment of 6,000 doses of Moderna’s COVID-19 vaccine arrived in Houston on Monday, marking the city government’s first batch of the potentially life-saving shots.
The arriving vaccines include 3,000 doses each for the Health Department and the Fire Department. Health workers and emergency medical technicians are first in line to get those vaccines, and they began getting the shots immediately Monday.
Mayor Sylvester Turner and his top medical administrators toured the vaccination site. The mayor wat...
Source: JEMS: Journal of Emergency Medical Services News - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed COVID-19 Houston Texas Source Type: news
Firefighters Next in Line for Vaccine
By JOHN HANNA and MIKE STOBBE Associated Press
NEW YORK (AP) — A federal advisory panel recommended Sunday that people 75 and older and essential workers like firefighters, teachers and grocery store workers should be next in line for COVID-19 shots, while a second vaccine began rolling out to hospitals as the nation works to get the coronavirus pandemic under control.
The two developments came amid a vaccination program that began only in the last week and has given initial shots to about 556,000 Americans, according to the Centers for Disease Control and Prevention.
The COVID-19 vaccine developed by Pfizer Inc...
Source: JEMS: Journal of Emergency Medical Services News - December 21, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Medicine Source Type: news
Are New Coronavirus Strains Cause for Concern?
By MARILYNN MARCHIONE AP Chief Medical Writer
Reports from Britain and South Africa of new coronavirus strains that seem to spread more easily are causing alarm, but virus experts say it’s unclear if that’s the case or whether they pose any concern for vaccines or cause more severe disease.
Viruses naturally evolve as they move through the population, some more than others. It’s one reason we need a fresh flu shot each year.
New variants, or strains, of the virus that causes COVID-19 have been seen almost since it was first detected in China nearly a year ago.
On Saturday, Prime Minister Boris Johnson ann...
Source: JEMS: Journal of Emergency Medical Services News - December 21, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news
U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer
NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic.
Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019.
U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are counted.
...
Source: JEMS: Journal of Emergency Medical Services News - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news
Studies Find Having COVID-19 May Protect Against Reinfection
By MARILYNN MARCHIONE AP Chief Medical Writer
Two new studies give encouraging evidence that having COVID-19 may offer some protection against future infections. Researchers found that people who made antibodies to the coronavirus were much less likely to test positive again for up to six months and maybe longer.
The results bode well for vaccines, which provoke the immune system to make antibodies — substances that attach to a virus and help it be eliminated.
Researchers found that people with antibodies from natural infections were “at much lower risk … on the order of the same kind of protection you’d g...
Source: JEMS: Journal of Emergency Medical Services News - December 26, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news
Overview of COVID-19 mortality in Zoram Medical College, Mizoram: A hospital-based study
CONCLUSIONS: COVID-19 is more severe in the older age group above 65 years of age and in males, particularly in the presence of underlying co-morbidities. Mortality was also higher in patients with no history of vaccination as compared with patients vaccinated. Also, delay in hospital admission increases the length of hospital stay and mortality.PMID:37091016 | PMC:PMC10114571 | DOI:10.4103/jfmpc.jfmpc_1251_22
Source: Primary Care - April 24, 2023 Category: Primary Care Authors: C Laltlanzovi C Vankhuma None Vanlalduhsaki Diana Lalrinsiami Chhakchhuak J C Zothanzauva Source Type: research
SARS-Cov-2 infection in cancer patients, susceptibility, outcome and care
We present a compilation of scientific facts and actual observations on different aspects of SARS-CoV-2 infection in cancer patients. These patients are at increased risk of viral contraction and have higher chances of severe disease/mortality. The latter is impacted by other factors and is still debated. In contrast to preliminary impressions, the benefits of anti-cancer treatments outweigh their risks and should be continued. Cancer patients generate antibodies in response to vaccination but in lower amounts than healthy people, especially those with hematologic cancers. Boosters, including third doses, have shown increa...
Source: The American Journal of the Medical Sciences - May 23, 2022 Category: General Medicine Authors: Mojgan Alaeddini Shahroo Etemad-Moghadam Source Type: research
Top White House Official Joins Baker In Boston For Beth Israel Tour
BOSTON (CBS) – A top White House official was in Boston Friday to get a closer look at the coronavirus response in Massachusetts. Health and Human Services Secretary Alex Azar visited the Beth Israel Deaconess Medical Center with Governor Charlie Baker to tour the hospital’s COVID-19 test kit assembly areas and learn more about the research there.
“There is no better place in this country to come learn about what’s going on with respect to COVID, with respect to treatments, with respect to testing, with respective vaccines, with respect to care, than right here and we really appreciate your being with us today,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 12, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Events Health Healthcare Status Politics Syndicated Local Alex Azar Beth Israel Deacones Medical Center Charlie Baker Coronavirus Source Type: news
Coronavirus means science is suddenly being done differently – and so is politics | Paul Nurse
The Nobel prize-winning scientist on how the pandemic is bringing dramatic shifts in medical researchSee all our coronavirus coverageCoronavirus – latest updatesIf we are to return to our normal lives, we need answers to many questions and they will only be delivered by science and medicine and their applications. In fact, the speed with which the virus has spread around the globe has been matched by the speed with which many scientists have mobilised themselves to take on this pandemic.The British science community has responded rapidly. The government ’s funding agency, UK Research and Innovation-Medical Research Cou...
Source: Guardian Unlimited Science - May 2, 2020 Category: Science Authors: Paul Nurse Tags: Medical research Coronavirus outbreak Infectious diseases Microbiology Science Vaccines and immunisation GlaxoSmithKline AstraZeneca Health Source Type: news
SARS-Cov-2 infection in cancer patients, susceptibility, outcome and care
We present a compilation of scientific facts and actual observations on different aspects of SARS-CoV-2 infection in cancer patients. These patients are at increased risk of viral contraction and have higher chances of severe disease/mortality. The latter is impacted by other factors and is still debated. In contrast to preliminary impressions, the benefits of anti-cancer treatments outweigh their risks and should be continued. Cancer patients generate antibodies in response to vaccination but in lower amounts than healthy people, especially those with hematologic cancers. Boosters, including third doses, have shown increa...
Source: The American Journal of the Medical Sciences - May 23, 2022 Category: General Medicine Authors: Mojgan Alaeddini Shahroo Etemad-Moghadam Source Type: research
Weekly Postings
Discussion – March 26-April 15
#CiteNLM Virtual Wikipedia Edit-a-thon – March 31, 1:00-3:00 PM ET
April 2021
Healthy Aging at Your Library: Connecting Older Adults to Health Information – April 9, 12:00-1:00 PM ET
From Being to Doing: Anti-Racism as Action at Work – April 13, 2:00-3:00 PM ET
Social and Environmental Determinants of Maternal Health Disparities and a Roadmap to Effective Solutions – April 20, 3:00-4:00 PM ET
PNR Rendezvous: Launching and Leading the Librarian Reserve Corps: Developing an agile librarian network in response to COVID-19 – April 21, 4:00-5:00 PM ET
On-Demand ...
Source: NN/LM Middle Atlantic Region Blog - February 26, 2021 Category: Databases & Libraries Authors: Tessa Zindren Tags: Weekly Postings Source Type: news
Illumina Helped the World Fight COVID-19. Now, CEO Francis deSouza Has Monkeypox in His Sights
As chief executive of San Diego-based genomic sequencing company Illumina, Francis deSouza feels well-placed to witness the world’s next great scientific transformation.
“I really believe that just like the 20th century was the era of the bit and the digital revolution, the 21st century is likely to be remembered as the era of the genome,” he says. “We’re seeing that play out in terms of genomic-based screening and diagnostics emerging, like Illumina’s offerings, but we’re also seeing the emergence of genomic-based medicine.”
DeSouza’s excitement is understandable. Well...
Source: TIME: Health - August 14, 2022 Category: Consumer Health News Authors: John Simons Tags: Uncategorized biztech2030 The Leadership Brief Source Type: news
Inside the Global Quest to Trace the Origins of COVID-19 —and Predict Where It Will Go Next
It wasn’t greed, or curiosity, that made Li Rusheng grab his shotgun and enter Shitou Cave. It was about survival. During Mao-era collectivization of the early 1970s, food was so scarce in the emerald valleys of southwestern China’s Yunnan province that farmers like Li could expect to eat meat only once a year–if they were lucky. So, craving protein, Li and his friends would sneak into the cave to hunt the creatures they could hear squeaking and fluttering inside: bats.
Li would creep into the gloom and fire blindly at the vaulted ceiling, picking up any quarry that fell to the ground, while his companion...
Source: TIME: Health - July 23, 2020 Category: Consumer Health News Authors: Charlie Campbell/ Yuxi, Yunnan and Alice Park Tags: Uncategorized COVID-19 feature Magazine Source Type: news
Vaccines, Antibodies and Drug Libraries. The Possible COVID-19 Treatments Researchers Are Excited About
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19.
It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
